Bell CJ, George CW, García CME, Rodríguez LJ, George BMJ

Language: Spanish
References: 10
Page: 628-637
PDF size: 386.25 Kb.

ABSTRACT

The case report of a 23 years female patient with clinical and radiographic diagnosis of Cronh disease for approximately 2 years who was admitted in the Internal Medicine Service of "Dr. Juan Bruno Zayas Alfonso ''Teaching General Hospital in Santiago de Cuba is presented for presenting prolonged feverish syndrome, intense migraine, myalgias, artralgia and polyserositis, with an unfavorable clinical course, besides complications that were emerging later on (heart, renal and respiratory failures). The results of the complementary exams and of pathological and histological studies carried out, reaffirmed the presence of progressive systemic sclerosis, which was confirmed later by means of skin biopsy. The treatment was indicated, according to the different clinical events and finally the patient was could be reinserted to the social life, but with certain limitations.

REFERENCES

1. Carreira P. Uso de inmunosupresores en la esclerodermia: cuándo, cuál y cuánto tiempo. Rev Sociedad Val Reumatol. 2013;5(1):20-2.

2. García Sevila R. Test de función pulmonar en la esclerodermia. Rev Sociedad Val Reumatol. 2013;5(1):9-11.

3. López Ferrer A, Barnadas MA, Rodríguez Arias JM, Geli C, Alomar A. Esclerodermia sistémica asociada a sarcoidosis con afectación cutánea: a propósito de un caso. Actas Dermosifiliogr. 2012;103(4):337-8.

4. Ozgen M, Koca SS, Isik A, Ozercan IH. Methotrexate has no antifibrotic effect in bleomycin-induced experimental scleroderma. J Rheumatol. 2010;37:678-9.

5. Balsa A. Definiendo la remisión en la artritis reumatoide: nuevos criterios de la ACR/EULA. Reumatol Clin. 2011;6(3):12-5.

6. Wipff J, Dieudé P, Guedj M, Ruiz B, Riemekasten G, Cracowski JL, et al. Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European caucasian population. Arthritis Rheumt. 2010; 62(10):3093-100.

7. Manetti M, Allanore Y, Revillod L, Fatini C, Guiducci S, Cuomo G, et al. A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. Arthritis Rheum. 2011; 63:247-56.

8. Bossini Castillo L, Martín JE, Díaz Gallo LM, Rueda B, Martín J. Genética de la esclerodermia. Reumatol Clin. 2010;6(2):12-5.

9. Bassyouni IM, Gheita TA, Talaat RM. Clinical significance of serum levels of sCD36 in patients with systemic sclerosis: preliminary data. Rheumatology. 2011; 50:2108-12.

10. López Ferrer A, Barnadas MA, Rodríguez Arias JM, Geli C, Alomar A. Esclerodermia sistêmica asociada a sarcoidosis con afectación cutánea: a propósito de un caso. Actas Dermosifiliogr. 2012;103(4):337-8.